Recipient of federal assistance · LITTLE ROCK, AR

ACETAMINOPHEN TOXICITY DIAGNOSTICS, LLC

ACETAMINOPHEN TOXICITY DIAGNOSTICS, LLC received -$212.1K in federal grants and other assistance in FY2026, on 1 actions, −120% vs FY2025. It has no federal contracts in the loaded years. Since FY2022: $3.2M.

Assistance · FY2026
-$212.1K
New awards
0
Actions
1
Since FY2022
$3.2M
UEI
M7PNUQVP4RE3
Location
LITTLE ROCK, AR
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 1.1MFY2022
  2. 1.3MFY2023
  3. 0FY2024
  4. 1.1MFY2025
  5. -212.1KFY2026

By type

  1. Grants-$212.1K0.0%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research-$212.1K0.0%

Largest awards

  1. ACETASTAT VALIDATION AND COMMERCIALIZATION - JAMES, LAURA P PROJECT SUMMARY/ABSTRACT ACETAMINOPHEN (APAP) IS THE MOST COMMON DRUG USED FOR…$3.2M
    93.847 · Diabetes, Digestive, and Kidney Diseases Extramural Research· National Institutes of Health· Project grant· Mar 30, 2022 – Jun 22, 2026· SB1DK079387

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2022–FY2026.